POM · POMDOCTOR Ltd · Financials

$0.93 +0.07 (+7.56%) At close · Oct 5

Market Cap

$9.64M

9.27M

Volume · Oct 5 52.84K Avg daily vol (3M) 62.05K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Diluted EPS

-$56.52

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	FY2025	FY2024	FY2023
EPS (Basic) USD/shares	-$56.52	—	—
EPS (Diluted) USD/shares	-$56.52	—	—
Shares Outstanding (Basic Avg) shares	537.81K	350.57K	350.57K
Shares Outstanding (Diluted Avg) shares	537.81K	350.57K	350.57K

Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Long-term debt, including current maturities	2025-12-31	CNY 81,824,073	20-F filed 2026-05-14
Long-term debt, including current maturities	2025-12-31	USD 11,700,687	20-F filed 2026-05-14
Operating lease liabilities	2025-12-31	CNY 2,839,512	20-F filed 2026-05-14
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities CNY 1,545,002 Noncurrent operating lease liabilities CNY 1,294,510
Operating lease liabilities	2025-12-31	USD 406,044	20-F filed 2026-05-14
Related accounting measures — not additional borrowing Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year. Current operating lease liabilities USD 220,932 Noncurrent operating lease liabilities USD 185,112
Short-term borrowings	2025-12-31	CNY 53,000,000	20-F filed 2026-05-14
Short-term borrowings	2025-12-31	USD 7,578,899	20-F filed 2026-05-14

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

—

EV/EBIT

—

P/E (TTM)

—

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (CNY)

Component	FY2025	FY2024	FY2023
Pharmaceuticals Supply Chain	249,202,806	253,518,320	233,844,000
Internet Hospital	150,712,158	89,039,600	71,008,971

By Product & Service (CNY)

Component	FY2025	FY2024	FY2023
Pharmacy Wholesale	243,239,143	246,879,121	227,561,751
Online Pharmacy Sales and Other Sales Revenue	149,235,145	87,849,203	69,644,697
Pharmacy Retail Sales	5,963,663	6,639,199	6,282,249
Online Consultation Service and Other Service Revenue	1,477,013	1,190,397	1,364,274

Key facts CIK 1877971 CUSIP 73181R207 Visit website Investor relations